Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay - Wikidata - awgldk - TriplyDB

Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay

Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay

http://www.wikidata.org/entity/Q35181330

about

GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs Comparison of TaqMan(®) Array Card and MYCOTB(TM) with conventional phenotypic susceptibility testing in MDR-TB.Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests.Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.Evolution of Phenotypic and Molecular Drug Susceptibility Testing.Nanowire sensors monitor bacterial growth kinetics and response to antibiotics.

P2860

Q28068545-C8E91AF1-7018-4829-8AAA-F15D20A3C17E Q30276393-0301E7A1-4EB5-48D3-A900-A19231E7E512 Q36165509-046781EB-68B3-4310-AC02-864D8E5D1287 Q36730001-2B0CA6E0-6577-4004-BEA0-0A8EA7B64D71 Q37120071-48CCA9CA-1693-40F9-B48F-F6BD000C4517 Q38839490-0C644E7D-9FB0-4994-95B5-449383DD9DA2 Q39412049-EC8EF5E8-76BE-4996-9450-087EDD74010B Q40043590-2A2CAA5C-2247-40BA-A75B-06C37515AA5C Q40409813-A1C4F061-D245-4DAA-8047-5F772487674C Q47237569-017A790E-4EFB-4F6F-B69E-488C681CABC6 Q47632774-4F11CC72-C88A-4703-A21E-0557B7721E17 Q50101557-40152AD6-FECC-47B0-8885-945FC4D35FDF

P2860

Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay

http://www.wikidata.org/entity/Q35181330

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay

@ast

Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay

@en

type

label

Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay

@ast

Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay

@en

prefLabel

Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay

@ast

Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay

@en

P1433

Q35181330-94BD27E4-2A66-4801-8D8F-671D19C0AD54

P1476

Q35181330-8D961B5E-D265-41A7-AE50-F0B193DA5666

P2093

Q35181330-0A78F34C-401B-4D58-B31D-C2CC4F2DDBFC

Q35181330-12276790-94D2-41DF-B20B-E7C573421AAE

Q35181330-3384DB3B-B691-4E22-B534-25602342E5F5

Q35181330-5343F350-A335-41F8-A395-5333F30365B1

Q35181330-66D5F7A0-77D9-44B5-9E40-9E8D7A723BFF

Q35181330-7BB66D55-6759-4BC2-93AF-277EA41AD903

Q35181330-BCE7DFB3-763D-4B2C-883B-1EB3EEE729B8

Q35181330-C05BFFCA-EAEC-43E9-867D-F64FC25F9EC5

Q35181330-F4107F10-AD84-406E-AAD1-59C6CB323306

P2860

Q35181330-123FAF63-5CCA-472D-91A4-C43E8F6022B0

Q35181330-163452A0-9DD3-4C64-8B3D-73CD0CF53582

Q35181330-1F75B017-05E1-4D12-82F8-E5864423C28A

Q35181330-2E4435B8-22CD-4645-898E-2055629FDE17

Q35181330-39D3834E-C9ED-4E8F-B93C-269256ABC773

Q35181330-3B5901CF-FD3F-4EC0-AD30-F9E1689E14DE

Q35181330-4A97AD1A-E76B-417D-86B7-99B4806B2E50

Q35181330-56133130-8C19-474E-9F04-B9A046B74AEF

Q35181330-59B7EC00-455F-4508-A0B2-E33FAC47BCA7

Q35181330-648518A9-26CB-40A4-B16C-20BF2AA6915B

P304

Q35181330-8EB69B67-5EBF-4CD3-9570-B0623E93D9AF

P31

Q35181330-0FC9A581-E5B9-448B-958C-4B861849F382

P356

Q35181330-5655CF15-239A-40C1-8758-AC7443D1A55E

P433

Q35181330-51C18F01-AA1F-429E-AB4F-81E2FD49EAA0

P478

Q35181330-D69690D5-C7EC-4673-96F7-5073D05CCF82

P577

Q35181330-08219922-9507-47C6-B85B-663F01847010

P698

Q35181330-F9F1B46B-B663-481E-877D-772C7ED862D0

P932

Q35181330-1C484F5F-D326-466C-AE5A-D6E863271B1A

P356

J.TUBE.2014.11.003

P1433

P1476

Correlating Minimum Inhibitory ...... ing the genotype MTBDRsl assay

@en

P2093

Anjali Shetty

http://www.w3.org/2001/XMLSchema#string

Antonino Catanzaro

http://www.w3.org/2001/XMLSchema#string

Camilla Rodrigues

http://www.w3.org/2001/XMLSchema#string

Chaitali Nikam

http://www.w3.org/2001/XMLSchema#string

Kanchan Ajbani

http://www.w3.org/2001/XMLSchema#string

Meeta Sadani

http://www.w3.org/2001/XMLSchema#string

Priti Kambli

http://www.w3.org/2001/XMLSchema#string

Timothy C Rodwell

http://www.w3.org/2001/XMLSchema#string

Zarir Udwadia

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.

Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model

Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.

Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay.

Fluoroquinolones, tuberculosis, and resistance.

A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.

Drug-susceptibility testing in tuberculosis: methods and reliability of results.

Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.

P304

137-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TUBE.2014.11.003

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25522842

http://www.w3.org/2001/XMLSchema#string

P932

4361297

http://www.w3.org/2001/XMLSchema#string